Cidara Therapeutics, Inc. — Form D

Cidara Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-05-30. The offering totals $1.9M, of which $1.6M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (39)

Showing 25 of 39 people.

NameRoleLocation
Robert J PerezDirectorSan Diego, CA
Scott M RocklageDirectorSan Diego, CA
Matthew R OnaitisExecutive OfficerSan Diego, CA
Daniel D BurgessDirectorSacramento, CA
Dirk ThyeExecutive OfficerSouth San Francisco, CA
Carin R Canale-TheakstonDirectorSan Diego, CA
Laura R Tadvalkar, Ph.D.DirectorSan Diego, CA
Taylor R Sandison, M.D.Executive OfficerSan Diego, CA
Leslie R Tari, Ph.D.Executive OfficerSan Diego, CA
Preetam R Shah, Ph.D.Executive OfficerSan Diego, CA
Bonnie R Bassler, Ph.D.DirectorSan Diego, CA
James R Merson, Ph.D.DirectorSan Diego, CA
Ryan R SpencerDirectorSan Diego, CA
Shane R WardExecutive OfficerSan Diego, CA
Jeffrey Stein, Ph.D.DirectorSan Diego, CA
Jeffrey Stein, Ph.D.Executive OfficerSan Diego, CA
Nina KjellsonDirectorSanta Clara, CA
Patrick HeronDirectorPhiladelphia, PA
Kevin JudiceDirectorSouth San Francisco, CA
Kevin JudiceExecutive OfficerSouth San Francisco, CA
Jeffrey SteinDirectorSan Francisco, CA
Jeffrey SteinExecutive OfficerSan Francisco, CA
Scott RocklageDirectorMenlo Park, CA
Theodore R SchroederDirectorSan Diego, CA
David R GollaherDirectorSan Diego, CA

Other filings by this issuer (6)

FiledFormOfferingSold
2024-05-06D$240.0M$240.0M
2019-09-13D$9.0M$9.0M
2017-10-31D$20.2M$20.2M
2015-02-17D$42.0M$42.0M
2014-06-17D$42.7M$30.3M
2014-06-17D$6.0M$6.0M

More